CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS

Majzner Robbie; Nellan Anandani; Heitzeneder Sabine; Theruvath Johanna; Mackall Crystal

首页> 外文期刊>Pediatric blood & cancer >CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS

【24h】

CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS

机译：靶向B7-H3的CAR T细胞，泛癌抗原，证明了对儿科实体肿瘤和脑肿瘤的有效的临床前活性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2018年第1期|共2页
作者
Majzner Robbie; Nellan Anandani; Heitzeneder Sabine; Theruvath Johanna; Mackall Crystal;
展开▼
作者单位

Stanford Univ Sch Med Palo Alto CA 94304 USA;

Stanford Univ Sch Med Palo Alto CA 94304 USA;

Stanford Univ Sch Med Palo Alto CA 94304 USA;

Stanford Univ Sch Med Palo Alto CA 94304 USA;

Stanford Univ Sch Med Palo Alto CA 94304 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors [J] . Majzner Robbie G., Theruvath Johanna L., Nellan Anandani, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第8期

机译：靶向B7-H3的CAR T细胞，泛癌抗原，证明了对儿科实体肿瘤和脑肿瘤的有效的临床前活性
2. CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS [J] . Majzner Robbie, Nellan Anandani, Heitzeneder Sabine, Pediatric blood & cancer . 2018,第Suppla1期

机译：靶向B7-H3的CAR T细胞，泛癌抗原，证明了对儿科实体肿瘤和脑肿瘤的有效的临床前活性
3. CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS [J] . Majzner Robbie, Nellan Anandani, Heitzeneder Sabine, Pediatric blood & cancer . 2018,第Suppla1期

机译：靶向B7-H3的CAR T细胞，泛癌抗原，证明了对儿科实体肿瘤和脑肿瘤的有效的临床前活性
4. KTN0182A, an Anti-KIT, Pyrrolobenzodiazepine (PBD)-Containing Antibody Drug Conjugate (ADC) Demonstrates Potent Antitumor Activity In Vitro and In Vivo Against a Broad Range of Tumor Types [C] . Sergio Trombetta, Christine Lubeski, Gary C. Kemp, PEGS . 2015

机译：KTN0182A，抗试剂盒，吡咯唑二氮杂己酮（PBD）抗体药物缀合物（ADC）在体外和体内抗抗肿瘤类型的抗肿瘤活性
5. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor in solid tumors. [D] . Priceman, Saul Jonathan. 2009

机译：通过抑制实体瘤中的CSF-1受体靶向不同的浸润肿瘤的骨髓细胞。
6. Tandem CAR-T cells targeting CD70 and B7-H3 exhibit potent preclinical activity against multiple solid tumors [O] . Meijia Yang, Xin Tang, Zongliang Zhang, 2020

机译：靶向CD70和B7-H3的串联CAR-T细胞对多种实体瘤表现出强大的临床前活性
7. Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 Via Chimeric Antigen Receptor T Cells [O] . Hongwei Du, Koichi Hirabayashi, Sarah Ahn, 2018

机译：通过嵌合抗原受体T细胞靶向B7-H3，在实体瘤中没有毒性的抗肿瘤反应

CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS

著录项

相似文献

相关主题

期刊订阅